Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies

ICAM-1 signaling in endothelial cells

(2014) Charlotte Lawson et al.   Pharmacological Reports

Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)

(2012) Christie M. Ballantyne et al.   AMERICAN JOURNAL OF CARDIOLOGY

Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)

(2011) Harold E. Bays et al.   AMERICAN JOURNAL OF CARDIOLOGY

Eicosapentaenoic Acid for the Prevention of Recurrent Atrial Fibrillation

(2011) Eiichi Watanabe et al.   ANNALS OF NONINVASIVE ELECTROCARDIOLOGY

Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease

(2011) Hiroshige Itakura et al.   Journal of Atherosclerosis and Thrombosis

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

(2011) Michael H. Davidson et al.   Journal of Clinical Lipidology

Adiposopathy

(2011) Harold E. Bays   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia

(2010) Ann C Skulas-Ray et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Inflammation in Atherosclerosis:

(2010) Peter Libby et al.   CIRCULATION JOURNAL

Omega-3 fatty acids and lipoprotein associated phospholipase A2 in healthy older adult males and females

(2010) T. L. Nelson et al.   EUROPEAN JOURNAL OF NUTRITION

Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology

(2009) Irena Levitan et al.   ANTIOXIDANTS & REDOX SIGNALING

An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals

(2009) M A Micallef et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome

(2009) Noriko Satoh et al.   HYPERTENSION RESEARCH

Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia

(2009) Michael H. Davidson et al.   Journal of Clinical Lipidology

DHA Supplementation Decreases Serum C-Reactive Protein and Other Markers of Inflammation in Hypertriglyceridemic Men

(2009) Darshan S. Kelley et al.   JOURNAL OF NUTRITION

Effect of eicosapentaenoic and docosahexaenoic acid on resting and exercise-induced inflammatory and oxidative stress biomarkers: a randomized, placebo controlled, cross-over study

(2009) Richard J Bloomer et al.   Lipids in Health and Disease

Review of the Evidence for the Clinical Utility of Lipoprotein-Associated Phospholipase A2 as a Cardiovascular Risk Marker

(2008) Marshall A. Corson et al.   AMERICAN JOURNAL OF CARDIOLOGY

Inverse relation between levels of anti-oxidized-LDL antibodies and eicosapentanoic acid (EPA)

(2008) L. Garrido-Sánchez et al.   BRITISH JOURNAL OF NUTRITION

The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults

(2008) Maria Weinkouff Pedersen et al.   EUROPEAN JOURNAL OF NUTRITION

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE